Cholesterol Med May Slow Vision Loss With Diabetes

Published on June 25, 2024

A well-established cholesterol-lowering drug appears to significantly slow the progression of a diabetes-related eye disease, a new trial shows. Fenofibrate (Tricor) has been approved since 2004 as a means of lowering cholesterol. Now, this new study shows that fenofibrate…

Read Full Article (External Site)